These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24396110)

  • 1. Lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapy.
    Hill LG
    Ann Pharmacother; 2013 Dec; 47(12):1740. PubMed ID: 24396110
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapy".
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013 Dec; 47(12):1741. PubMed ID: 24311729
    [No Abstract]   [Full Text] [Related]  

  • 3. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phentermine plus topiramate in the treatment of obesity.
    Malgarini RB; Pimpinella G
    Lancet; 2011 Jul; 378(9786):125-6; author reply 126-7. PubMed ID: 21742167
    [No Abstract]   [Full Text] [Related]  

  • 5. Two new drugs approved for obesity.
    Johnson AM
    S D Med; 2012 Sep; 65(9):356-7. PubMed ID: 23066610
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination phentermine and topiramate for weight maintenance: the first Australian experience.
    Neoh SL; Sumithran P; Haywood CJ; Houlihan CA; Lee FT; Proietto J
    Med J Aust; 2014 Aug; 201(4):224-6. PubMed ID: 25164851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What cost weight loss?
    Hiatt WR; Thomas A; Goldfine AB
    Circulation; 2012 Mar; 125(9):1171-7. PubMed ID: 22392864
    [No Abstract]   [Full Text] [Related]  

  • 8. Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration.
    Grabarczyk TR
    Pharmacotherapy; 2018 Jan; 38(1):19-28. PubMed ID: 29044720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phentermine plus topiramate in the treatment of obesity.
    Cohen PA
    Lancet; 2011 Jul; 378(9786):126; author reply 126-7. PubMed ID: 21742168
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiobesity pharmacotherapy: new drugs and emerging targets.
    Kim GW; Lin JE; Blomain ES; Waldman SA
    Clin Pharmacol Ther; 2014 Jan; 95(1):53-66. PubMed ID: 24105257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phentermine and topiramate extended release (Qsymia™): first global approval.
    Cameron F; Whiteside G; McKeage K
    Drugs; 2012 Oct; 72(15):2033-42. PubMed ID: 23039320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit.
    Cunningham JW; Wiviott SD
    Clin Cardiol; 2014 Nov; 37(11):693-9. PubMed ID: 25223901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Pharmacotherapy.
    Saunders KH; Umashanker D; Igel LI; Kumar RB; Aronne LJ
    Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?
    Woloshin S; Schwartz LM
    JAMA Intern Med; 2014 Apr; 174(4):615-9. PubMed ID: 24515599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.
    Garvey WT
    Expert Opin Drug Saf; 2013 Sep; 12(5):741-56. PubMed ID: 23738843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate and phentermine: a long story...
    Prescrire Int; 2013 Mar; 22(136):62. PubMed ID: 23593687
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
    Gadde KM; Allison DB; Ryan DH; Peterson CA; Troupin B; Schwiers ML; Day WW
    Lancet; 2011 Apr; 377(9774):1341-52. PubMed ID: 21481449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and safety of the new anti-obesity medications.
    Hainer V; Aldhoon-Hainerová I
    Drug Saf; 2014 Sep; 37(9):693-702. PubMed ID: 25096956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.
    Jordan J; Astrup A; Engeli S; Narkiewicz K; Day WW; Finer N
    J Hypertens; 2014 Jun; 32(6):1178-88. PubMed ID: 24621808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.